2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
39
Nausea
31
Neoplasms
10
Breast Neoplasms
10
Lymphoma
9
Multiple Myeloma
7
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Leukemia, Myeloid, Acute
6
Sezary Syndrome
4
Myeloproliferative Disorders
4
Leukemia
4
Carcinoma, Non-Small-Cell Lung
4
Pruritus
3
Primary Myelofibrosis
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pdgfra-Associated Chronic Eosinophilic Leukemia
3
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Neutrophilic, Chronic
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Interventions
Dexamethasone
5
ramosetron
3
Ondansetron
2
Calcium Dobesilate
2
Acupuncture Therapy
2
phenazine
1
esmolol
1
Therapeutics
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Olanzapine
1
Gelatin
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Aprepitant
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Analgesics, Opioid
1
Adrenergic beta-Antagonists
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Postoperative Nausea and Vomiting
×
Aprepitant
×
Clear all
NCT01046461
2012-02-17
RAD
Hallym University Medical Center
Phase 2
Unknown
41 enrolled